Hereditary persistence of fetal hemoglobin is exactly what it sounds like – instead of completely shutting down fetal hemoglobin production after birth like most people do, ...

We had previously reported the presence of an apparent increase in Type II hexokinase activity in the red cells of a patient homozygous for the hereditary persistence of fetal hemoglobin, and in ...

Scientists have been looking for ways to increase fetal hemoglobin in more people with sickle cell disease, says Ambroise Wonkam, M.D., Ph.D., the Henry J. Knott Director of the McKusick-Nathans ...

BEAM-101 BEACON Trial Represents the First Clinical Trial of a Base Editor in the United StatesCAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a ...

Treatment with BEAM-101 demonstrated robust and durable increases in fetal hemoglobin (HbF) and reductions in ... of naturally occurring variants seen in hereditary persistence of fetal hemoglobin.

CAMBRIDGE, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, announces new safety ...

Persistence of fetal hemoglobin in erythrocytes of normal children. Pediatrics 9:469–473, 1952. Crossref. PubMed. Web of Science. ... GENETIC LINKAGE WITH THE RH CHROMOSOME, Australasian ...

Treatment with BEAM-101 demonstrated robust and durable increases in fetal hemoglobin (HbF) and reductions in ... of naturally occurring variants seen in hereditary persistence of fetal hemoglobin.

CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that ...

Updated data from 17 patients treated with BEAM-101 demonstrated robust and durable increases in fetal hemoglobin (HbF) and ... variants seen in hereditary persistence of fetal hemoglobin.